Sigla
Commercial- Indications
- Dementia
Company intelligence / Profile preview
Mentis Cura has developed a cloud-based digital diagnostic platform that uses machine learning to analyze EEG data for early detection of CNS disorders. Their technology has been validated on a database of over 3,000 patients followed for more than a decade. Two CE-marked products are available commercially in Europe. Clinical results indicate robust accuracy for early diagnosis of dementia and ADHD.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mentis Cura.